During the past decade, Sanatorio Británico conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 11 clinical trials were completed, i.e. on average, 68.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 11 clinical trials were completed. i.e. 183.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sanatorio Británico" #1 sponsor was "Janssen Research & Development, LLC" with 7 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Daiichi Sankyo, Inc." with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "University of Minnesota" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanatorio Británico" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator and "ARTTIC International Management Services" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Sanatorio Británico" are "Diabetes Mellitus, Type 2" (2 trials), "Heart Failure" (2 trials), "Influenza A" (2 trials), "Systemic Lupus Erythematosus" (2 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Sanatorio Británico" in a lesser frequency.

Most popular intervention types in "Sanatorio Británico" are "Drug" (17 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Baricitinib" (2 trials), "Empagliflozin" (2 trials), "Pimodivir 600 mg" (2 trials) and "SOC Treatment" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sanatorio Británico" are 19 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Sanatorio Británico". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Sanatorio Británico, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Sanatorio Británico, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".